Navigation Links
CryoPort Creates Personal Wall on Wallst.net's Financial Social Community, my.wallst.net
Date:4/15/2008

NEW YORK, April 15 /PRNewswire-FirstCall/ -- CryoPort, Inc. (OTC Bulletin Board: CYRX) (http://www.CryoPort.com) will be updating the investment community through their personal profile on MyWallst.net available at http://www.wallst.net. The dynamic profile will include interviews with company representatives, on which investors can comment, and links to recent press.

Visit CryoPort's profile on Mywallst.net at http://my.wallst.net/profile.php?ID=19849.

Stay updated about CryoPort, Inc., post a comment on their personal page, join CryoPort's message board to discuss company activity with other interested parties, "invest" in OTCBB: CYRX through the Rookie Challenge and join his financial social network today.

About WallSt.net:

http://www.wallst.net is owned and operated by WallStreet Direct, Inc., a wholly owned subsidiary of Financial Media Group, Inc. (http://www.financialmediagroupinc.com). The Web site is a leading provider of timely business news, executive interviews, multimedia content, and research tools. Financial Media Group, Inc. also owns http://my.wallst.net, a financial social network for investors, and Financial Filings Corp. (http://www.financialfilings.com), a provider of compliance solutions to publicly traded companies. We have received nine hundred ninety five dollars from CryoPort, Inc. for media and advertising services. In addition to WallSt.net, WallStreet Direct, Inc. owns and operates WallStRadio (http://www.wallstradio.com), a business and finance podcast Web site.

About CryoPort, Inc.:

CryoPort develops leading edge, proprietary, technology-driven shipping and storage products for use in the rapidly growing global biotechnology and biopharmaceutical cold chain. The products developed by CryoPort are essential components of the infrastructure required for the testing, research and end user delivery of temperature-sensitive medicines and biomaterials in an increasingly complex logistical environment. The Company offers a complete end to end shipping solution with its products for pharmaceutical clinical trials, gene biotechnology, transport of infectious materials and dangerous goods and pharmaceutical distribution. It markets its services directly in the Americas, Europe, and Asia. The company was founded in 1999.

Contact: CryoPort, Inc.

Investor Relations

Stuart Fine

908-469-1788


'/>"/>
SOURCE CryoPort, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. ADVENTRX Creates Executive Vice President Position and Announces New Chief Financial Officer
2. MIT creates gecko-inspired bandage
3. Change in Medicare and Medicaid Legislation Creates Market for Antimicrobial Coatings In the U.S.
4. Digital Unions RT1(TM) Software Creates Telegenetics Network for Region 3 Genetics Collaborative
5. U.S. Preventive Medicine and deCODE Genetics Sign Letter of Intent to Expand Personalized Medicine Platform
6. Seduce with Mousse - Replens Introduces Intimate Options: First Personal Lubricant Mousse in Canada
7. WaferGen to Present at the Cambridge Health Institutes Fifth Annual Molecular Diagnostics Partnerships in Personalized Medicine Conference
8. Center for Molecular Medicine Partners with AviaraDx to Offer New Cancer Tests to Aid Physicians in Personalizing Treatment
9. Siemens and National Jewish Medical and Research Center Form Strategic Alliance to Advance Shared Vision of Personalized Medicine
10. Statement by John Bailey, Chief Scientist: The Personal Care Products Council Response to Study on Phthalate Exposure in Baby Care Products
11. AMDLs First Full Service JPGreen Health and Personal Care Center Set to Open in Hangzhou, China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... Alto, CA, USA (PRWEB) , ... October 11, 2017 , ... ... set to take place on 7th and 8th June 2018 in San Francisco, CA. ... policy influencers as well as several distinguished CEOs, board directors and government officials from ...
(Date:10/11/2017)... ... 2017 , ... Disappearing forests and increased emissions are the main causes of ... year. Especially those living in larger cities are affected by air pollution related diseases. ... most pollution-affected countries globally - decided to take action. , “I knew I had ...
(Date:10/10/2017)... Angeles, CA (PRWEB) , ... ... ... Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, ... uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in ...
(Date:10/10/2017)... 2017 SomaGenics announced the receipt of a ... RealSeq®-SC (Single Cell), expected to be the first commercially ... microRNAs) from single cells using NGS methods. The NIH,s ... accelerate development of approaches to analyze the heterogeneity of ... techniques for measuring levels of mRNAs in individual cells ...
Breaking Biology Technology:
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" or ... independent Directors Mr. Robin D. Richards and Mr. ... the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer said," ... and benefiting from their considerable expertise as we move forward ...
(Date:4/4/2017)... YORK , April 4, 2017   EyeLock ... today announced that the United States Patent and Trademark ... patent broadly covers the linking of an iris image ... same transaction) and represents the company,s 45 th ... latest patent is very timely given the multi-modal biometric ...
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
Breaking Biology News(10 mins):